Nyxoah vs Inspire : Which Implant for Which Patient

Sunday, October 12, 2025

1:00 PM - 2:00 PM EDT

Location: 136

CME/MOC Credit: 1

Disclosure(s):

Martin L. Hopp, MD PhD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Maria V. Suurna, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

David T. Kent, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: With the FDA approval of Nyxoah OSA Hypoglossal nerve stimulator (expected First Quarter 2005), , the decision of which Hypoglossal Nerve Stimulator is appropriate for which patient is controversial. This panel of expert experienced Sleep Surgeons will present real OSA cases including DISE when appropriate, and present a discussion of recommended therapy and the results of the surgery. . The risk and potential complications will also be discussed.

Learning Objectives:

Become knowledgeable the differences with Inspire vs Nyxoah Therapy
Become knowledgeable of the patient characteristics that are appropriated for Inspire and Nyxoah Therapy
Become knowledgeable of the results and complications in actual patients having undergone Inspire or Nyxoah Therapy.

Moderator(s)

Martin L. Hopp, MD PhD

Director, OSA Treatment Center, Cedars Sinai Med Center
Cedars-Sinai Medical Center
Los Angeles, CA, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Panelist(s)

Maria V. Suurna, MD

Professor
University of Miami
Miami, Florida, United States

Disclosure information not submitted.
MD

Mark D'Agostino, MD

Southern New England Ear, Nose and Throat, United States

Disclosure information not submitted.
David T. Kent, MD

Associate Professor, Department of Otolaryngology - Head and Neck Surgery
Vanderbilt University
Nashville, TN, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.